DS Biopharma
Trintech Building, South
County Business Park
Leopardstown
Dublin
18
Tel: 353-1-2933-590
Website: http://www.dsbiopharma.com/
Email: info@dsbiopharma.com
About DS Biopharma
DS Biopharma is a biopharmaceutical drug discovery and development company working on new medicines that improve the quality of life for people with diseases for which existing therapies are ineffective.YEAR FOUNDED:
2010
LEADERSHIP:
CEO: John Climax
CFO: Mark O’Neill
CSO (Scientific): Mehar Manku
JOBS:
Please click here for DS Biopharma job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
7 articles about DS Biopharma
-
DS Biopharma and Nuvothera Enter Option and License Agreement for EPADILIN®
3/18/2021
Nuvothera acquires option to licence rights to develop and commercialise DS Biopharma’s EPADILIN® in the US
-
DS Biopharma Announces That Recruitment Has Begun In Two Separate Phase 2b Atopic Dermatitis Studies With Lead Compound DS107 As Well As The Successful Completion Of A Phase 1 Trial For Follow On Compound DS109
1/6/2017
-
DS Biopharma Will Today Present Data On A Phase IIa Study At The European Academy Of Dermatology And Venereology (EADV) Congress
9/29/2016
-
DS Biopharma Announces The Appointment Of Dr. Markus Weissbach As Chief Operating Officer
9/14/2016
-
DS Biopharma Spins Out New Company Focused on Fibrotic Conditions and Pulmonary Disorders
8/22/2016
-
DS Biopharma Announces DS102 Will Be Developed For Pulmonary Disorders In Addition To NASH
5/23/2016
-
DS Biopharma Presents Late-Breaking News Abstract On DS102 At The European Association For The Study Of The Liver (EASL) International Liver Congress; "DS102: A Bioactive Lipid For The Treatment Of NASH"
4/14/2016